Other changes in the developing TME such as hypoxia, lactate production and modified cytokine production also help to establish immunosuppression and evasion favoring more aggressive tumor progression, particularly given that high TGFβ production by advanced stage breast cancer cells is strongly immunosuppressive [75, 76] and will promote the N2 neutrophils. The gene discussed is TGFB1; the disease is neoplasm.